我武生物：关于获得豚草花粉点刺液药物临床试验补充申请批准通知书的公告

Core Viewpoint - The company has received approval for a clinical trial supplement application for its drug "Artemisia pollen puncture solution" from the National Medical Products Administration [2] Group 1 - The company announced on November 21 that it obtained the approval notification for the clinical trial supplement application [2] - The approval was downloaded from the official website of the National Medical Products Administration [2] - The drug in question is referred to as "Artemisia pollen puncture solution" [2]